Roster of Vendors
Angela Radcliffe - AI Training and Courses
Individuals or teams seeking to build practical AI knowledge can participate in one of Angela’s free or paid programs to learn how to use AI and build custom tools that streamline everyday tasks. As an AI, data, and health literacy advocate, Angela is well-versed in the many AI tools available to businesses and is also a published author in the field.
Target Customers: Small- to mid-sized biopharma companies, CROs, patient recruitment firms, life sciences agencies, and other organizations seeking streamlined processes.
Pricing and Time Commitment: Angela offers a free, 1-hour interactive virtual course introducing participants to a variety of AI tools and demonstrating their potential impact on business operations. Following this introductory session, participants may enroll in her intensive 30-day online program for a flat fee (significantly lower than comparable consulting fees). This program equips individuals and teams with the expertise to automate daily tasks, build custom GPTs, and position their business for scalable growth.
Guarantee: If a participant completes the 30-day program but is not yet proficient in applying AI to improve their processes, Angela provides ongoing 1:1 coaching until they are capable.
ESPERO - Digital-First eProtocol
ESPERO is transforming clinical research through digital protocol intelligence—turning unstructured study documents into standardized, analyzable data that powers smarter design, faster startup, and more informed site selection. By connecting ICH-M11 and USDM standards with real-world insights, ESPERO enables sponsors and partners to move confidently toward a future of data-driven research. The platform replaces static, manual workflows with dynamic, digital processes that improve collaboration, enhance compliance, and accelerate clinical development. With ESPERO, teams achieve greater efficiency, visibility, and quality across the entire clinical trial lifecycle.
PA1.ai - Biomarkers for Central Nervous System
PA1.ai accelerates and optimizes central nervous system (CNS) drug development by identifying likely responders, non-responders, and placebo responders before a clinical trial begins. Its AI-powered platform delivers a suite of predictive neuroimaging biomarkers for CNS conditions, integrating multimodal data across the following:
Cognitive profiles
Brain activity
Psychopathological, clinical, and demographic measures
By improving the quality and predictive strength of trial outcomes, PA1.ai increases the probability of therapeutic success and reduces sponsor costs through the early detection and exclusion of non-responders and placebo responders (meta-analyses indicate placebo response rates exceeding 40% in modern CNS trials). The result is smaller, faster, and more efficient clinical trials.
PharmaAcuity - Empowering Clinical Operations and Medical Affairs Teams
In an era where clinical development timelines have stretched from 8.2 to nearly 12 years, every operational delay and strategic misstep compounds cost and risk. With R&D investments reaching up to $4.5 billion per asset, efficiency and precision in execution are paramount. PharmaAcuity provides an AI-powered co-pilot purpose-built for Clinical Operations and Medical Affairs teams — accelerating decision-making, optimizing trial design, and ensuring the right evidence is generated to support both regulatory and market success. Their solutions enable your teams to:
Streamline trial planning and execution
Build, refine, and continuously update Target Product Profiles (TPPs) to align clinical objectives with regulatory pathways and real-world market needs
Identify the highest-performing trial sites and most engaged investigators to drive faster enrollment and better data quality
Strengthen evidence generation and medical engagement
Map key opinion leaders, principal investigators, and referral networks to amplify trial visibility and enhance scientific collaboration
Integrate competitive intelligence and medical insights into a unified strategic roadmap — connecting development milestones with future launch readiness
By transforming fragmented data into actionable intelligence, PharmaAcuity empowers Clinical Operations and Medical Affairs to work in lockstep — accelerating trials, reducing cost, and ensuring every study advances the science and the strategy behind it.